International Journal of Cancer Management

Published by: Kowsar

Clinical Experience with Glioblastoma Multiforme in Pediatric Patients

Mahmoud Reza Khalatbari 1 , * and Yashar Moharamzad 1
Authors Information
1 Department of Neurosurgery, Arad Hospital, Tehran, Iran
Article information
  • International Journal of Cancer Management: December 2017, 10 (12); e8100
  • Published Online: December 31, 2017
  • Article Type: Letter
  • Received: August 4, 2016
  • Accepted: December 12, 2017
  • DOI: 10.5812/ijcm.8100

To Cite: Khalatbari M R, Moharamzad Y. Clinical Experience with Glioblastoma Multiforme in Pediatric Patients, Int J Cancer Manag. 2017 ;10(12):e8100. doi: 10.5812/ijcm.8100.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnotes
References
  • 1. Khalatbari MR, Hamidi M, Moharamzad Y. Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature. Childs Nerv Syst. 2011;27(8):1347-52. doi: 10.1007/s00381-011-1492-z. [PubMed: 21656012].
  • 2. Sanchez Herrera F, Castro Sierra E, Gordillo Dominguez LF, Vaca Ruiz MA, Santana Montero B, Perezpena Diazconti M, et al. Glioblastoma multiforme in children, experience at hospital infantil de Mexico Federico Gomez. Childs Nerv Syst. 2009;25(5):551-7. doi: 10.1007/s00381-008-0780-8. [PubMed: 19148652].
  • 3. Ansari M, Nasrolahi H, Kani AA, Mohammadianpanah M, Ahmadloo N, Omidvari S, et al. Pediatric glioblastoma multiforme: A single-institution experience. Indian J Med Paediatr Oncol. 2012;33(3):155-60. doi: 10.4103/0971-5851.103142. [PubMed: 23248421].
  • 4. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol. 1995;13(1):112-23. doi: 10.1200/JCO.1995.13.1.112. [PubMed: 7799011].
  • 5. Khalatbari MR, Khalatbari S, Moharamzad Y. Fatal intratumoral hemorrhage in tectal plate glioblastoma multiforme following ventriculoperitoneal shunt. J Pediatr Neurosci. 2014;9(2):192-5. doi: 10.4103/1817-1745.139366. [PubMed: 25250086].
  • 6. Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011;13(3):317-23. doi: 10.1093/neuonc/noq191. [PubMed: 21339192].
  • 7. Broniscer A, Chintagumpala M, Fouladi M, Krasin MJ, Kocak M, Bowers DC, et al. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol. 2006;76(3):313-9. doi: 10.1007/s11060-005-7409-5. [PubMed: 16200343].
  • 8. Hart MG, Garside R, Rogers G, Stein K, Grant R. Temozolomide for high grade glioma. Cochrane Database Syst Rev. 2013;30(4):7415. doi: 10.1002/14651858.CD007415.pub2. [PubMed: 23633341].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments